Dry suspension containing cefixime liposome and preparation method thereof

A technology of cefixime and dry suspension, which is applied in the field of medicine, can solve the problems of poor solubility, stability and bioavailability, and achieve the effects of improving bioavailability, sufficient drug effect, and less toxic and side effects

Inactive Publication Date: 2011-02-16
王丽燕
View PDF13 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] Chinese patents CN101606913A and CN101401810A disclose cefixime dispersible tablets and their preparation methods. The dispersible

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dry suspension containing cefixime liposome and preparation method thereof
  • Dry suspension containing cefixime liposome and preparation method thereof
  • Dry suspension containing cefixime liposome and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0070] Example 1: Preparation of Cefixime Liposome

[0071] Name of raw materials

[0072] Preparation:

[0073] (A) Dissolve hydrogenated soy lecithin, hydrogenated egg yolk lecithin, cholesterol, and polysorbate 80 in an appropriate amount of absolute ethanol according to the prescribed amount, and mix well to obtain solution I; the amount of absolute ethanol used is the amount of cefixime 30 times;

[0074] (B) Weigh the prescribed amount of cefixime, add an appropriate amount of phosphate buffer with a pH of 7.0 to completely dissolve it to obtain a cefixime solution;

[0075] (C) Weigh povidone K according to the prescription amount 30 , Add the above phosphate buffer to dissolve and prepare povidone K with a concentration of 0.78mg / ml 30 Solution; Then add the above-mentioned cefixime solution and mix well to obtain solution II;

[0076] (D) Using a pipette pump, inject solution I into solution II, and stir continuously at a high speed to completely hydrate the phospholipid me...

Example Embodiment

[0081] Example 2: Preparation of Cefixime Liposome

[0082] Name of raw materials

[0083] Preparation:

[0084] (A) Dissolve hydrogenated soy lecithin, hydrogenated egg yolk lecithin, cholesterol, and polysorbate 80 in an appropriate amount of absolute ethanol according to the prescribed amount, and mix well to obtain solution I; the amount of absolute ethanol used is the amount of cefixime 25 times;

[0085] (B) Weigh the prescribed amount of cefixime, add an appropriate amount of phosphate buffer with a pH of 7.5 to completely dissolve it to obtain a cefixime solution;

[0086] (C) Weigh povidone K according to the prescription amount 30 , Add the above-mentioned phosphate buffer to dissolve and prepare povidone K with a concentration of 0.66mg / ml 30 Solution; Then add the above-mentioned cefixime solution and mix well to obtain solution II;

[0087] (D) Using a pipette pump, inject solution I into solution II, and stir continuously at a high speed to completely hydrate the phosp...

Example Embodiment

[0092] Example 3: Preparation of Cefixime Liposome

[0093] Name of raw materials

[0094] cholesterol

[0095] Preparation:

[0096] (A) Dissolve hydrogenated soy lecithin, hydrogenated egg yolk lecithin, cholesterol, and polysorbate 80 in an appropriate amount of absolute ethanol according to the prescribed amount, and mix well to obtain solution I; the amount of absolute ethanol used is the amount of cefixime 30 times;

[0097] (B) Weigh the prescribed amount of cefixime, add an appropriate amount of phosphate buffer with a pH of 7.9 to completely dissolve it to obtain a cefixime solution;

[0098] (C) Weigh povidone K according to the prescription amount 30 , Add the above-mentioned phosphate buffer to dissolve and prepare povidone K with a concentration of 0.80mg / ml 30 Solution; Then add the above-mentioned cefixime solution and mix well to obtain solution II;

[0099] (D) Using a pipette pump, inject solution I into solution II, and stir continuously at a high speed to comp...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to cefixime liposome and preparation method therefore as well as dry suspension containing the cefixime liposome. The dry suspension is composed of the cefixime liposome and pharmaceutically acceptable carriers, wherein the cefixime liposome comprises the following components in parts by weight: 1 part of cefixime, 1.25-5 parts of hydrogenated soybean lecithin, 1.25-5 parts of hydrogenated yolk lecithin, 2.5-10 parts of cholesterol and 0.1-5 parts of polysorbate 80. The dry suspension not only accords with the requirements of Chinese pharmacopoeia, but also has the advantages of better storage stability in normal temperature, faster effect exertion and obviously improved bioavailability in comparison with the common cefixime medicaments.

Description

technical field [0001] The invention relates to a cefixime liposome, a preparation method thereof and a dry suspension containing it. The cefixime dry suspension is more stable than common cefixime pharmaceutical compositions when stored at room temperature, The invention has the advantages of faster drug effect and significantly improved bioavailability, belonging to the field of medical technology. Background technique [0002] Acute pelvic inflammatory disease refers to the acute inflammation of female pelvic reproductive organs and its surrounding connective tissue and pelvic peritoneum, including metritis, salpingo-oophoritis, pelvic connective tissue inflammation and pelvic peritonitis, which can occur in one or several places at the same time. One of the common diseases. The development of acute pelvic inflammatory disease can cause diffuse peritonitis, sepsis, septic shock, and severe cases can be life-threatening. Lower abdominal pain accompanied by fever at the t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/127A61K47/34A61P15/00A61P31/00A61K31/546A61K9/16A61K47/26
Inventor 王丽燕
Owner 王丽燕
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap